Solana Company (HSDT) Financial Analysis & Valuation | Quarter Chart
Solana Company (HSDT)
HSDTPrice: $2.09
Fair Value: 🔒
🔒score
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the... more
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellne... more
Description
Shares
| Market Cap | $84.23M | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Dane Carl Andreeff |
| IPO Date | 2014-06-27 | CAGR | — |
| Employees | 21 | Website | solana.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
HSDT chart loading...
Fundamentals
Technicals
| Enterprise Value | $-191.19M | P/E Ratio | — |
| Forward P/E | -2.15 | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | — |
| P/CF Ratio | — | P/FCF Ratio | — |
| EPS | $-829.83 | EPS Growth 1Y | 103034.87% |
| EPS Growth 3Y | 4435.7% | EPS Growth 5Y | 809.91% |
| Revenue Growth 1Y | 87.45% | Gross Margin | 0.5% |
| Operating Margin | -48.81% | Profit Margin | -393.59% |
| ROE | 10.29% | ROA | -0.78% |
| ROCE | -0.1% | Current Ratio | 40.03 |
| Quick Ratio | 39.67 | Cash Ratio | 39.52 |
| Debt/Equity | — | Interest Coverage | -72.22 |
| Altman Z Score | -1.54 | Piotroski Score | 4 |